Medicare Enrolled

Dr. Michelle Vartanian, O.D.

Optometrist · West Hills, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
7320 WOODLAKE AVE, West Hills, CA 91307
8188830112
In practice since 2007 (19 years)
NPI: 1326175464 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vartanian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vartanian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vartanian

Dr. Michelle Vartanian is an optometrist in West Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vartanian performed 1,201 Medicare services across 969 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vartanian received a total of $6,933 from 26 pharmaceutical and/or device companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vartanian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in CA $6,933 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,201
Medicare services
Top 6% in CA for optometrist
969
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~63 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
362 $71 $145
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
212 $32 $240
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
196 $96 $198
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
118 $30 $103
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
88 $52 $114
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
84 $27 $240
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
61 $94 $261
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
55 $23 $53
Telephone or electronic assessment, 5-10 minutes
A remote assessment and management service conducted via telephone, internet, or electronic health record. The consulting physician spends 5 to 10 minutes providing verbal and written reports.
13 $13 $120
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
12 $107 $233
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,933
Total received (2018-2024)
Avg $990/year across 7 years
Top 3% in CA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
126
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,348 (91.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$585 (8.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$775
2023
$1,320
2022
$1,081
2021
$664
2020
$386
2019
$1,922
2018
$786

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$192
Bausch & Lomb Americas Inc.
$148
SUN PHARMACEUTICAL INDUSTRIES INC.
$122
NEW WORLD MEDICAL,INC.
$89
ABBVIE INC.
$76
Alcon Vision LLC
$67
RxSight Inc
$34
Oyster Point Pharma, Inc.
$28
BIOTISSUE HOLDINGS INC.
$19
Top 3 companies account for 59.6% of 2024 payments
All-time payments by company (2018-2024) ›
Johnson & Johnson Vision Care, Inc.
$929
Shire North American Group Inc
$918
Alcon Vision LLC
$901
Sun Pharmaceutical Industries Inc.
$599
Allergan, Inc.
$513
Glaukos Corporation
$498
Bausch & Lomb, a division of Bausch Health US, LLC
$482
Aerie Pharmaceuticals, Inc.
$378
Bausch & Lomb Americas Inc.
$247
Novartis Pharmaceuticals Corporation
$219
BIOTISSUE HOLDINGS, INC.
$166
Allergan Inc.
$128
Kala Pharmaceuticals, Inc.
$125
Dompe US, Inc.
$123
SUN PHARMACEUTICAL INDUSTRIES INC.
$122
Regeneron Pharmaceuticals, Inc.
$110
ABBVIE INC.
$105
RxSight Inc
$101
NEW WORLD MEDICAL,INC.
$89
Oyster Point Pharma, Inc.
$51
AbbVie Inc.
$47
Thea Pharma Inc.
$21
BIOTISSUE HOLDINGS INC.
$19
Carl Zeiss Meditec, Inc.
$17
NovaBay Pharmaceuticals, Inc.
$15
Eyevance Pharmaceuticals LLC
$11
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
ALPHAGAN P · AcrySof · Acuvue · Avenova · CE-marked KXLA system · Centurion · Cequa · Clareon · DAILIES · DURYSTA · EYSUVIS · Flarex · IYUZEH · KXL system (not refurbished) · Kahook Dual Blade · LUMIGAN · MIEBO · None Specified · OXERVATE · PROKERA · Precision 1 · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSTOR · Rhopressa · Rocklatan · TOTAL30 · TYRVAYA · VUITY · VYZULTA · Wavelight Refractive Suite · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for optometrist in CA.

Looking for an optometrist in West Hills?
Compare optometrists in the West Hills area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
881
Per 100K population
8.9
County median income
$87,760
Nearest hospital
UCLA WEST VALLEY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vartanian is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vartanian experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Vartanian performed 362 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vartanian receive payments from pharmaceutical companies?
Yes. Dr. Vartanian received a total of $6,933 from 26 companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vartanian's costs compare to other optometrists in West Hills?
Dr. Vartanian's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vartanian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →